ArticleInternational immunopharmacology2022

Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period.

Manojit Bhattacharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.